Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 3,913 | 6,246 | 20,407 | 121,910 | 4,665 |
| Cost of Goods | 1,226 | 1,311 | 980 | 1,085 | 816 |
| Gross Profit | 2,687 | 4,935 | 19,427 | 120,825 | 3,849 |
| Operating Expenses | 31,284 | 37,792 | 55,205 | 23,993 | 18,123 |
| Operating Income | -28,371 | -32,546 | -34,798 | 96,917 | -13,458 |
| Interest Expense | 45,009 | 1,052 | 963 | 1,208 | 1,200 |
| Other Income | -2,806 | 24 | 33,779 | -36,776 | -1,479 |
| Pre-tax Income | -76,186 | -33,574 | -1,982 | 58,933 | -16,137 |
| Income Tax | -1,377 | -948 | -90,424 | 57,480 | -1,398 |
| Net Income Continuous | -74,809 | -33,548 | 48,198 | 1,453 | -14,739 |
| Minority Interests | -945 | -974 | -246 | 3,514 | -552 |
| Net Income | $-73,864 | $-32,574 | $48,444 | $-2,061 | $-14,187 |
| EPS Basic Total Ops | -0.73 | -0.38 | 0.81 | -0.03 | -0.20 |
| EPS Basic Continuous Ops | -0.74 | -0.40 | 0.82 | 0.02 | -0.21 |
| EPS Diluted Total Ops | -0.73 | -0.38 | 0.81 | -0.03 | -0.20 |
| EPS Diluted Continuous Ops | -0.74 | -0.40 | 0.82 | 0.02 | -0.21 |
| EBITDA(a) | $-25,931 | $-30,540 | $-33,386 | $99,084 | $-11,519 |